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Abstract
Background:  Anesthesia is produced by a depression of central nervous system function,
however, the sites and mechanisms of action underlying this depression remain poorly defined. The
present study compared and contrasted effects produced by five general anesthetics on synaptic
circuitry in the CA1 region of hippocampal slices.
Results: At clinically relevant and equi-effective concentrations, presynaptic and postsynaptic
anesthetic actions were evident at glutamate-mediated excitatory synapses and at GABA-mediated
inhibitory synapses. In addition, depressant effects on membrane excitability were observed for
CA1 neuron discharge in response to direct current depolarization. Combined actions at several
of these sites contributed to CA1 circuit depression, but the relative degree of effect at each site
was different for each anesthetic studied. For example, most of propofol's depressant effect (> 70
%) was reversed with a GABA antagonist, but only a minor portion of isoflurane's depression was
reversed (< 20 %). Differences were also apparent on glutamate synapses-pentobarbital depressed
transmission by > 50 %, but thiopental by only < 25 %.
Conclusions: These results, in as much as they may be relevant to anesthesia, indicate that general
anesthetics act at several discrete sites, supporting a multi-site, agent specific theory for anesthetic
actions. No single effect site (e.g. GABA synapses) or mechanism of action (e.g. depressed
membrane excitability) could account for all of the effects produced for any anesthetic studied.
Background
General anesthetics have been shown to depress neuronal
responses in virtually all brain areas studied and this
depression has been proposed to result from actions at
GABAA-mediated inhibitory synapses and postsynaptic
chloride channels [1-4], potassium channels [5-7], or cal-
cium channels [8-11], and/or at glutamate-mediated exci-
tatory synapses [12-17]. The last decade has seen a major
shift in our understanding of general anesthetic mecha-
nisms of action, away from a non-specific Unitary theory
of action, towards a detailed view of anesthetic actions at
membrane receptor and ion channel targets for these
agents [18,19]. It is likely that several anesthetic actions
occurring at independent sites contribute in additive ways
to depress neuronal circuits in higher brain structures.
Alternatively, anesthetic effects could result from actions
at only a few sites and this should become evident by
studying overall effects on the CA1 neural circuit and
'chasing down' the underlying actions. In the present
study, the effects produced by five general anesthetics
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were studied at several possible sites of action within the
well characterized Schaffer-collateral to CA1 neuron cir-
cuit using electrophysiological recordings from rat hip-
pocampal slices. The CA1 circuit has previously been
shown to be depressed by anesthetics from several chem-
ical classes [20-26] at concentrations which alter hippoc-
ampal electrical activity in chronically instrumented rats
during anesthesia [27-29]. The five agents chosen for this
study are all clinically used anesthetics and provide a good
representation from unique chemical classes: a halocar-
bon (halothane), halogenated ether (isoflurane), barbitu-
rate (pentobarbital), sulfonated-barbiturate (thiopental),
and a newer di-isopropylphenol compound, propofol.
Results and discussion
Anesthetics enhance GABA-mediated inhibition
All five anesthetics depressed synaptically evoked dis-
charge, measured as a block of population spike (PS)
responses recorded from CA1 neurons (Fig. 1). The two
volatile anesthetics, halothane and isoflurane, produced a
nearly complete depression (to 3.3 ± 3.5 and 5.6 ± 7.1 %
of control respectively) at clinically effective concentra-
tions: halothane (1.0 rat MAC; 1.25 vol % ~ 250 µM) and
isoflurane (1.0 rat MAC; 1.55 vol % ~ 350 µM; for
Sprague-Daley rats [30]; Minimum Alveolar Concentra-
tion – the expired anesthetic gas concentration for a 50 %
loss of a tail clamp response – motor reflex in rats). The
three intravenous agents, pentobarbital (400 µM), thio-
pental (80 µM) and propofol (30 µM), also depressed PS
responses to a comparable degree: 1.7 ± 3.1, 3.4 ± 2.8 and
6.2 ± 5.8 % of control responses, respectively (p < 0.001,
n ≥ 5 slices from individual rats, for all five agents com-
pared with pre-anesthetic control responses, using
ANOVA-Tukey). All anesthetic effects were reversible on
washout of the agent with drug free ACSF. It should be
noted that the more lipophilic intravenous anesthetics
produce lower effect site concentrations in these brain
slices than the applied concentrations shown, especially
for these short time periods of application, because it can
take several hours for these agents to diffuse 200 to 300
µm into brain slices and achieve steady-state levels [31].
For example, an applied concentration of 30 µM propofol
would be expected to produce only ~ 1.0 to 3.0 µM at a
recording depth of 250 microns within 30 minutes [32].
The volatile anesthetics, in contrast, rapidly equilibrate
throughout the brain slice due to their relatively high
aqueous solubility.
These equi-effective applied concentrations for PS depres-
sion were used in subsequent experiments to determine
whether this depression resulted from enhanced GABAA-
mediated inhibition.
A GABAA receptor antagonist, bicuculline, was applied in
the continued presence of each anesthetic to attempt to
reverse the anesthetic-induced PS depression. Bicuculline
(10 µM) reversed anesthetic-induced PS depression to var-
ying degrees for each agent: isoflurane – 16.2 ± 7.4 %,
halothane – 22.3 ± 18.4 %, pentobarbital – 56.2 ± 12.4 %,
thiopental – 64.9 ± 12.9 % and propofol – 69.5 ± 14.3 %.
Similar degrees of reversal were observed using the GABA-
chloride channel blocker, picrotoxin (100 µM; a supra-
maximal blocking concentration). A GABAB  receptor
antagonist, CGP 55845A (10 µM) did not reverse PS
depression for any of the anesthetics studied (see Table 1).
None of the anesthetics produced a significant depression
of antidromically stimulated PS responses (± 5 % depres-
sion, p > 0.15) indicating that CA1 neuron axonal con-
duction was not appreciably altered. Thus, enhanced
GABAA-mediated inhibition appeared to play a major role
for the PS depression produced by propofol and thiopen-
tal (~ 75 %), less so for pentobarbital (~ 50 %), and con-
tributed only partially to the depressant effects of the
volatile anesthetics (< 25 %; Fig. 1E).
Anesthetics depress glutamate-mediated excitatory 
synapses
To determine whether anesthetic-induced PS depression
resulted from depressed glutamate-mediated excitatory
synaptic inputs to CA1 neurons, field excitatory postsyn-
aptic potentials (EPSPs) were recorded from dendritic
regions in stratum radiatum. All five anesthetics depressed
EPSP responses (e.g. Fig. 1C and 1D): isoflurane to 52.2 ±
7.6 (p < 0.001), halothane 61.3 ± 8.4 (p < 0.001), pento-
barbital 54.5 ± 4.8 (p < 0.001), thiopental 75.5 ± 9.8 (p <
0.01) and propofol 72.7 ± 23.5 (p < 0.05) % of control
responses. Bicuculline did not reverse volatile anesthetic-
induced EPSP depression, but did partially reverse the
effect for pentobarbital (11.4 ± 3.6 %) and completely
reversed the EPSP depression produced by thiopental and
propofol (Fig. 1F). Thus, depressed glutamate-mediated
synaptic excitation appeared to play an important role for
PS depression produced by isoflurane, halothane and
pentobarbital. The thiopental and propofol-induced EPSP
depression would also contribute to PS depression for
these agents, but appeared to occur via enhanced GABA-
mediated inhibition at a dendritic level, since this depres-
sion was reversed by bicuculline.
Pre- and postsynaptic sites of action at GABAA synapses
Whole cell voltage clamp recordings from CA1 neurons
were used to examine more closely anesthetic effects on
membrane currents at GABA synapses. Spontaneous
GABA-mediated inhibitory postsynaptic currents (IPSCs)
were observed in all CA1 neurons studied (n = 15) and
were completely blocked by bicuculline (10 µM; Fig. 2A).
In the presence of glutamate receptor antagonists (CNQX
17.2  µM and APV 100 µM) the anesthetics produced
agent-specific effects on holding currents needed to clamp
neurons at the control resting membrane potentials (-60BMC Neuroscience 2004, 5:52 http://www.biomedcentral.com/1471-2202/5/52
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Anesthetic-induced depression of CA1 neuron responses involve actions at both glutamate and GABA-mediated synapses Figure 1
Anesthetic-induced depression of CA1 neuron responses involve actions at both glutamate and GABA-mediated synapses. (A) 
Halothane depressed population spike (PS) responses at clinically relevant concentrations (1 rat MAC = 1.2 vol % ~ 250 µM) 
and this depression was only partially reversed using a GABAA receptor antagonist, bicuculline (BIC). (B) Propofol (30 µM) 
produced a comparable degree of population spike depression compared to halothane, but this depression was substantially 
reversed with BIC, indicating that enhanced GABA-mediated inhibition contributes > 75 % of the depressant effect of propofol. 
The representative recordings shown are for propofol effects at 10 minutes following exposure to anesthetic (i.e. at 30 min on 
the x axis for the grouped data) and after 30 minutes of exposure, when a nearly complete block of the population spike was 
apparent. (C) Excitatory postsynaptic potentials (EPSP) were also depressed by halothane and this effect was not reversed by 
BIC, indicating a direct effect of the anesthetic on glutamate-mediated synapses. (D) Propofol-induced depression of glutamate-
mediated EPSPs, in contrast, appeared to involve enhanced GABA-mediated inhibition, since this depression was completely 
reversed by BIC. The two anesthetics exhibited quite different sensitivities to reversal by BIC, indicating that actions at GABA 
synapses vary for these agents. For each graph, data were normalized and each point represents the mean ± SD for at least five 
measures from different slices made from separate animals. Horizontal bars indicate the time of exposure to each drug. Sample 
recordings from representative experiments are shown in the top traces. (E) BIC reversal of anesthetic-induced population 
spike depression was agent specific for equieffective levels of depression, and data are summarized for four anesthetics as bar 
graphs. Shaded bars represent the degree of depression produced by each anesthetic and open bars show the extent of 
reversal produced by BIC, error bars indicate SD for at least five measures from different slices. Volatile agents (isoflurane – 
ISO, 350 µM; halothane – HAL, 250 µM) were only weakly reversed by BIC, while intravenous agents (pentobarbital – PEN, 
400 µM; thiopental – THIO, 80 µM; propofol-PRO, 30 µM) were more sensitive to the GABA receptor antagonist. (F) A simi-
lar profile of agent specific effects for BIC reversal was evident for glutamate-mediated EPSP responses, volatile agent effects 
were poorly reversed while intravenous agents appeared to be more sensitive to the GABA antagonist.
AB
CD
EF
120
80
40
0
60 50 40 30 20 10 0
120
80
40
0
70 60 50 40 30 20 10 0
120
80
40
0
70 60 50 40 30 20 10 0
CONTROL HALOTHANE (1 MAC) OVERLAY CONTROL PROPOFOL (30 µM) PROPOFOL (30 µM)
CONTROL PROPOFOL (30 µM) PROPOFOL + BIC CONTROL HALOTHANE (1 MAC) OVERLAY
TIME (MINUTES) TIME (MINUTES)
HALOTHANE (1 MAC)
BIC (10 µM)
BIC (10 µM)
BIC (10 µM)
BIC (10 µM)
PROPOFOL (30 µM)
PROPOFOL (30 µM)
0.5 mV
25 ms
0.5 mV
25 ms
10 min 30 min
E
P
S
P
(
%
C
O
N
T
R
O
L
)
P
S
(
%
C
O
N
T
R
O
L
)
4.0 mV
25 ms
4.0 mV
25 ms
120
80
40
0
60 50 40 30 20 10 0
HALOTHANE (1 MAC)
%
E
F
F
E
C
T
POPULATION SPIKE
ISO HAL PEN PRO
0
60
20
40
80
100
GLUTAMATE-MEDIATED EPSP
ISO HAL PEN PRO
DEPRESSION
BIC RECOVERY 60
40
20
0
THIO THIOBMC Neuroscience 2004, 5:52 http://www.biomedcentral.com/1471-2202/5/52
Page 4 of 10
(page number not for citation purposes)
to -70 mV). Propofol was most effective at increasing
holding currents (376 ± 83 pA, n = 3), followed by thio-
pental (320 ± 72 pA, n = 4) and pentobarbital (127 ± 65
pA, n = 3). Halothane (n = 6) and isoflurane (n = 3) pro-
duced weaker and more variable responses (< 50 pA). The
changes in holding currents produced by propofol and
the barbiturates were reversed by bicuculline (10 µM) or
picrotoxin (100 µM), indicating that they involved activa-
tion of GABAA-mediated chloride channels.
The most dramatic effect produced by all five anesthetics
was observed on IPSCs (e.g. Fig. 2B). Membrane charge
transfer, for example, was increased by 3 to 4 fold in the
presence of halothane and came about by at least two sep-
arate mechanisms. The first mechanism was a prolonga-
tion of IPSC time course (Fig. 2C) resulting in nearly a 3
fold increase in charge transfer for each IPSC (284 ± 33 %
of control, p < 0.005, n = 6). This result was in good agree-
ment with previous findings showing that anesthetics pro-
long IPSCs by increasing the open time of GABA-gated
channels in the postsynaptic membrane [33-35]. The sec-
ond mechanism appeared to involve presynaptic sites,
observed as an increase in frequency of IPSCs (143 ± 28 %
of control, p < 0.005, n = 6 neurons from separate slices)
and occurred with a small, but significant, depression in
IPSC amplitudes (92 ± 6 % of control, p < 0.05, n = 6). The
anesthetic-induced IPSC frequency increase was also
observed in the presence of tetrodotoxin, used to block
action potentials (n = 5 for halothane, n = 4 for propofol),
indicating a direct action on GABA nerve terminals. This
confirms earlier findings that anesthetics can increase
IPSC frequency and the release of GABA from nerve termi-
nals [36-39]. This presynaptic effect combines with posts-
ynaptic prolongation of IPSCs to account for the marked
increase in membrane charge transfer observed, and
would contribute to the anesthetic-induced postsynaptic
hyperpolarization of CA1 neurons previously reported
[4,40-42]. All of the anesthetics studied increased inhibi-
tory charge transfer and the degree of enhancement corre-
sponded well with the ability of bicuculline to reverse the
anesthetic-induced depression of population spike
responses (Fig. 1 and Table 1). For halothane and isoflu-
rane, this enhanced inhibitory charge transfer played a rel-
atively minor role in population spike depression
compared with their ability to depress glutamate-medi-
ated excitatory inputs to the CA1 neurons.
Anesthetics increase paired-pulse facilitation
To determine whether presynaptic actions also contribute
to anesthetic effects at glutamate synapses, paired pulse
(120 ms) facilitation of Schaffer-collateral evoked EPSPs
were studied. In the presence of either halothane or isoflu-
rane no apparent change in EPSP rise time or decay kinet-
ics were observed (Fig. 3A), contrasting with the marked
prolongation of IPSC decay time produced by the anes-
thetics. Facilitation was increased to nearly 115 % of con-
trol and this effect was independent of GABAA-mediated
actions, since they persisted in the presence of the antago-
nist – bicuculline (Fig. 3B). This increase in facilitation is
consistent with a presynaptic depression of glutamate
release from nerve terminals, perhaps via depressant
actions on voltage activated calcium or sodium channels
which couple axon spike depolarization to the release of
transmitter [8,9,17,43,44].
Anesthetics increase paired-pulse inhibition
Agent-specific effects were observed for paired pulse
inhibitory responses (120 ms separation) recorded from
CA1 neurons (Fig. 3C). Halothane and isoflurane pro-
duced no apparent change in paired pulse responses, both
the first and second population spike following a pair of
stimuli were depressed to a similar degree by these anes-
thetics. In contrast, propofol, thiopental and pentobarbi-
tal increased paired pulse inhibition, evident in a greater
Table 1: GABA antagonist effects on anesthetic-induced depression of population spike responses
Anesthetic Percent reversal of anesthetic-induced depression
Bicuculline Pictrotoxin CGP-GABAB
Propofol 69.5 ± 14.3 % 72.3 ± 8.2 % 3.1 ± 4.1%
Thiopental 64.9 ± 12.9 % 68.3 ± 9.7 % 1.3 ± 3.0%
Pentobarbital 56.2 ± 12.4 % 54.3 ± 11. 5% 0.8 ± 6.3 %
Halothane 22.3 ± 18.4 % 20.8 ± 15.3 % 0.5 ± 3.3 %
Isoflurane 16.2 ± 7.4 % 19.5 ± 10.2 % 3.4 ± 4.8 %
Notes: Bicuculline effects on propofol, thiopental and pentobarbital p < 0.01
Bicuculline effects on halothane and isoflurane p < 0.1
Picrotoxin effects on propofol, thiopental and pentobarbital p < 0.01
Picrotoxin effects on halothane and isoflurane p < 0.1
CGP effects were not significant for any anesthetic studied.BMC Neuroscience 2004, 5:52 http://www.biomedcentral.com/1471-2202/5/52
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degree of depression for the second of a pair of responses.
To quantify these increases in paired pulse inhibition,
effects on second pulse responses were compared at con-
centrations that produced a half maximal depression of
first spike responses. At a level of 50 % depression of first
pulse responses, pentobarbital produced a 134 ± 8 %
increase in second pulse inhibition, thiopental produced
a 156 ± 15 % increase and propofol produced a 149 ±
13% increase (p < 0.001, n = 5 for each agent compared to
first pulse responses). This effect is consistent with in vivo
Whole cell patch clamp recordings of spontaneous GABA-mediated inhibitory postsynaptic currents (IPSC) in CA1 neurons  revealed two sites of action for anesthetic-induced enhanced inhibition Figure 2
Whole cell patch clamp recordings of spontaneous GABA-mediated inhibitory postsynaptic currents (IPSC) in CA1 neurons 
revealed two sites of action for anesthetic-induced enhanced inhibition. (A) Spontaneous synaptic currents were blocked by a 
GABAA-receptor antagonist bicuculline (BIC), indicating that they were GABAA-mediated Cl- currents. Traces on the top show 
20 s of continuous recording from a CA1 neuron in control and in the presence of BIC. A rate meter graph (bottom) shows 
the relatively stable frequency of IPSCs during 20 min of control recording, followed by a rapid and complete block of 
responses produced by BIC (indicated by the bar). (B) Halothane produced a marked increase of the inhibitory charge transfer 
in CA1 neurons measured as the integral of current recordings (shaded area in top traces). A three fold increase of inhibitory 
charge (pico Colombs – pC) was reversibly produced by halothane and appeared to come about through both a prolongation 
of IPSC time course (C) and from an increased frequency of synaptic currents (D). Both effects persisted in the presence of 10 
µM tetrodotoxin (TTX) and/or glutamate receptor antagonists indicating that action potential dependent activity and glutamate 
synapses were not required for anesthetic action. For the rate meter histograms in (A) and (D), each bin represents the 
number of events recorded in 4 s divided by 4 to give a frequency in Hz (events/second). For all IPSC recordings a CsCl based 
internal solution was used in the patch pipette.BMC Neuroscience 2004, 5:52 http://www.biomedcentral.com/1471-2202/5/52
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Anesthetics act at several sites to depress CA1 neuron synaptically evoked discharge Figure 3
Anesthetics act at several sites to depress CA1 neuron synaptically evoked discharge. (A) Halothane appears to act presynapti-
cally to depress glutamate release, evidenced by an increase in paired pulse facilitation concomitant with EPSP depression. A 
similar increase in facilitation was produced by isoflurane and pentobarbital, but not by thiopental or propofol. No change in 
EPSP rise or decay time was apparent in the presence any anesthetic. (B) The increased facilitation produced by halothane, iso-
flurane and pentobarbital was not reversed by bicuculline (BIC) indicating a depressant effect on glutamate nerve terminals – 
independent of anesthetic effects at GABAA receptors. (C) Differential GABA effects were also evident for paired pulse inhibi-
tion of population spike responses. Volatile agents like halothane produced little or no paired pulse inhibition at concentrations 
that produced a half maximal depression of first pulse responses. In contrast, propofol increased paired pulse inhibition and 
similar effects were observed with thiopental and pentobarbital. This increase in paired pulse inhibition was reversed by bicuc-
ulline indicating that these anesthetics enhanced recurrent GABAA-mediated inhibition. (D) The anesthetics also appeared to 
act directly on CA1 pyramidal neuron membrane excitability to slow action potential discharge activity, although the intrave-
nous agents were much more effective compared to volatile anesthetics. None of the anesthetics produced an appreciable 
effect on individual action potential amplitude or time course (right: control – solid line; anesthetic – dotted, for halothane on 
top and propofol on bottom). (E) Anesthetics act at multiple sites to depress the CA1 neuron circuit. Sites of action are indi-
cated on a diagram of CA1 circuitry showing input from Schaffer-collateral fibers, local inhibitory interneurons (IN) and a CA1 
pyramidal neuron (triangle). Action potential propagation in Schaffer-collateral fibers (1) was depressed by ~ 15% by halothane 
and this contributes about 25 % to EPSP depression [60, 61]; see also [17]. This effect did not contribute to anesthetic-induced 
increases in facilitation, because no change in facilitation occurred when a comparable amount of action potential depression 
was produced by tetrodotoxin [61]. Further presynaptic depression at glutamate nerve terminals (2) was evident from the 
increased facilitation observed (Fig. 3A&3B) and there is also good evidence for postsynaptic depressant effects on both 
NMDA and AMPA receptors (3) [16, 19, 62, 63]. Anesthetics also act pre- and postsynaptically at GABA-mediated synapses (4, 
see Fig. 2) and can also increase tonic GABA-mediated inhibition by acting as GABA agonists in the absence of synaptically 
released GABA (5) [46-48]. Perisynaptic and extrasynaptic tonic GABAA receptors (7) also contribute to the postsynaptic 
depression produced by isoflurane [64] as well as thiopental and propofol [4, 65]. Enhanced recurrent inhibition (6) plays and 
important role for anesthetics in vivo [45] and strong effects were evident in the present study for propofol, thiopental and 
pentobarbital (Fig. 3C), similar to effects previously reported for halothane in hippocampal slices [26]. In addition, anesthetics 
also directly depress CA1 neuron excitability by blocking calcium channels and enhancing potassium currents contributing to 
hyperpolarization (8) and increased discharge thresholds [40, 41, 42, also Nishikawa, Beida & Maclver, unpublished]. These lat-
ter effects could influence CA1 neuron discharge activity for near threshold responses, but for the stronger stimuli used in the 
present study, effects on GABA and glutamate synapses and on postsynaptic receptors for these transmitters appear to con-
tribute most (~ 80 %) to the depressant actions observed.BMC Neuroscience 2004, 5:52 http://www.biomedcentral.com/1471-2202/5/52
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findings [45] and is thought to reflect a greater degree of
GABA-mediated inhibition contributing to the second of
a pair of stimuli, via recurrent (feedback) activation of
inhibitory interneurons caused by the first pulse [26].
Anesthetics depress CA1 neuron excitability
To determine whether the anesthetics could alter postsyn-
aptic membrane excitability, effects on action potentials
evoked by direct current injection into CA1 neurons were
studied. Differences in effect were apparent across anes-
thetic agents – hardly any effect was evident for halothane
and isoflurane, but the barbiturates and propofol pro-
duced a significant depression of action potential dis-
charge (Fig. 3D). When measured as a reduction in the
number of action potentials produced in response to a
one second long depolarizing current step, halothane pro-
duced an 8.2 ± 2.2 % depression and isoflurane an 11.6 ±
6.1 % depression (p < 0.01 for both agents compared to
control responses). Propofol was much more effective at
depressing CA1 discharge, producing a 93.5 ± 6.1 %
depression (p < 0.001). Thiopental produced a 90.3 ± 9.9
% depression and pentobarbital a 79.5 ± 7.4 % depression
(p < 0.001 for both anesthetics compared with control).
The anesthetic-induced depression of spike discharge
activity was accompanied by decreases in membrane
resistance and to a lesser extent by small changes in mem-
brane resting potential. In spite of the marked depressant
effects observed for the intravenous anesthetics on spike
discharge, none of the anesthetics appeared to alter action
potential amplitude, rise time or decay profiles (Fig. 3D),
suggesting that the major depressant effect was accounted
for by actions on spike threshold – not on the sodium cur-
rents which underlie action potentials per se.
Conclusions
Two conclusions can be drawn from these results: 1) for a
given anesthetic, like halothane, multiple sites of action
contributed in an additive manner to produce an overall
depression of transmission through the CA1 neuronal cir-
cuitry (Fig. 3E); 2) for each anesthetic the degree of effect
was agent specific at some of these sites. Together the
results support a Multisite Agent Specific (MAS) mecha-
nism of action for general anesthetics. This represents a
departure from traditional Unitary theories of action in
several important respects. Unitary theories posit that all
anesthetics act via a common molecular mechanism, such
as to change the fluidity of nerve cell membranes, or to
enhance a potassium current, or most recently to enhance
GABA-mediated inhibition [2,3]. With the MAS theory,
no common site of action is required (nor apparent) for
anesthetics. This is consistent with observations at the
molecular, [46-50] cellular [22,51] and behavioral levels
[52-55].
Differing degrees of action (efficacy) were evident at both
glutamate and GABA synapses for each anesthetic. For
example, our results demonstrate that the two barbitu-
rates studied appear to have differing degrees of effect at
GABA synapses since thiopental's depressant effects were
reversed ~ 65 % by a GABA antagonist, but pentobarbital's
effects were only reversed by ~ 55 %. Similarly, these two
barbiturates exhibited differing degrees of depression for
glutamate-mediated excitatory inputs to the CA1 neurons,
pentobarbital produced a 45 % depression in contrast to
thiopental with only a 25 % depression. It was interesting
that opposite actions were seen at presynaptic sites (GABA
release was increased by anesthetics, while glutamate
release was depressed) and at postsynaptic sites (GABA-
mediated synaptic currents were prolonged, glutamate-
mediated currents were not). The MAS theory can readily
account for the unique agent-specific profiles of effects
observed in various experimental models, and also seen
clinically – a long standing weakness of Unitary theories
[56]. Finally, the MAS theory predicts that agents which
selectively target GABA and glutamate synapses could lead
to the design of safer and more effective therapeutic agents
for anesthesia, that exhibit fewer undesirable side effects.
Glutamate and GABA synapses in the hippocampus are
among the best characterized synapses in the brain and
appear to utilize receptor subtypes which are similar to
those in neocortex, thalamus and other higher brain
regions. Thus, the effects described in the present study
would be expected to occur in these other brain regions as
well, but it should be noted that different GABA and gluta-
mate receptor subtype distributions are known to occur in
cerebellum, spinal and some brain stem nuclei, and it
remains to be determined whether anesthetics alter these
synapses in a similar manner to their hippocampal coun-
terparts. Ted Eger's group at UCSF has recently found that
enhanced GABA-mediated synaptic transmission at the
spinal level plays an important role for propofol-induced
immobility in response to a noxious stimulus [54], but
this was not the case for isoflurane-induced immobility
[57]. This agrees well with our findings that the volatile
anesthetic-induced depression of synaptic signaling
involves mechanisms other than enhanced GABA inhibi-
tion (see also [58]), while the depression produced by the
barbiturates and propofol are more dependent on
enhanced GABA-mediated inhibition. Additional in vivo
support comes from studies utilizing a GABA beta 3 recep-
tor mutant mouse model – proprofol-induced anesthesia
was blocked in these mice, while volatile anesthetic effects
were not [59]. Taken together with these in vivo findings,
our results indicate that effects on GABA synapses play a
role in anesthetic actions, especially for propofol, thio-
pental and pentobarbital; but the results also indicate that
effects on glutamate synapses and postsynaptic mem-
brane excitability contribute to the CNS depressionBMC Neuroscience 2004, 5:52 http://www.biomedcentral.com/1471-2202/5/52
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produced by all anesthetics. Given the multiple effects
observed for anesthetic actions on the two types of syn-
apses studied here, it is likely that effects on other neuro-
transmitter systems also contribute to anesthetic-induced
depression of the CNS.
Methods
Male Sprague-Dawley rats were anesthetized with ether
(22 vol % in air) and the brain was rapidly removed and
placed in ice cold (5°C) and pregassed (95/5 % O2/CO2,
carbogen) artificial cerebral spinal fluid (ACSF). The ACSF
had the following composition (in mM): Na 151.25; K
2.5; Ca 2.0; Mg 2.0; Cl 131.5; HCO3 26.0; SO4 2.0; H2PO4
1.25; and glucose 10. Whole brain coronal slices (450
µm) were cut using a vibratome (Campden Instruments),
following careful removal of the dura and pia mem-
branes. Hemisected brain slices were equilibrated for at
least one hour at room temperature in an incubation
chamber filled with ACSF and continually bubbled with
carbogen. Individual slices were transferred to a recording
chamber and equilibrated for an additional 10 minutes
prior to electrophysiological recording. Oxygenated ACSF
solution was continuously perfused through the chamber
at a flow rate of 3.0 ml/min and maintained at 22 ± 1°C.
The present studies were carried out at room temperature
because synaptic responses recorded from cooler brain
slices exhibit considerably better baseline stability and the
tissue remains viable for many more hours in vitro com-
pared to slices maintained at physiological temperatures.
Room temperature also facilitates the use of submerged
preparations (oxygen solubility and delivery to slices is
increased), which allows the use of 60× optics to visualize
single neurons for the patch clamp recordings used in
some experiments. Previous studies comparing both vola-
tile and intravenous anesthetic effects at physiological and
cooler temperatures in brain slices found that there were
no apparent differences in effects [43,61,66]. The most
important effect of lower temperature is to increase the
aqueous solubility of the volatile anesthetics and previous
work from our laboratory has described in detail the solu-
bility changes observed at 22 vs. 35°C and our methods
for measuring and compensating for changed aqueous
solubility, as well as the remarkably similar physiological
responses recorded from brain slices at these two temper-
atures [43,66].
To measure population spikes, bipolar tungsten microe-
lectrodes were placed on Schaffer-collateral fibers to elec-
trically stimulate inputs to hippocampal CA1 pyramidal
neurons. Glass recording electrodes filled with ACSF (2 to
5 KOhm) were placed in stratum pyramidale to record
stimulus-evoked population spike field potentials, or in
stratum radiatum to record field EPSPs. Single stimulus
pulses (0.01 to 0.05 ms duration; 10 to 80 µA @ 1.0 to 5.0
V) were delivered via constant current isolation units
(Grass Instruments, SIU 6D) from a Grass S8800 two
channel stimulator; at stimulus rates of 0.05 Hz. Field
potential signals were amplified (× 1000), filtered (1 Hz
to 10 KHz, bandpass), conditioned (DC offset), and digit-
ally stored for later analysis (A/D with 20 µs resolution on
a 486, and 50 MHz microcomputer using Data Wave Sys-
tems Corp. or Strathclyde Electrophysiological software).
Whole cell patch-clamp recordings were made using thin-
walled borosilicate capillaries (1.5 mm O.D.) pulled in
two stages on a Narishige PP83 pipette puller. Patch elec-
trodes were filled with the following intracellular solution
(in mM): potassium gluconate or CsCl2 – 100, EGTA –
10, MgCl2 – 5, HEPES free acid – 40, ATP disodium salt –
0.3, and GTP sodium salt -0.3. The electrode solution also
contained the local anesthetic QX 314 (1.0 mM) in some
experiments, to prevent action potential discharge that
would contaminate recordings of IPSCs. Electrode solu-
tions were filtered and pH adjusted to 7.2 using KOH or
CsOH and had a final osmolarity of 260 to 270 mOSM.
Patch electrodes with a DC resistance of 4 to 5 MOhm
were used. Recordings were made using an Axoclamp 2A
preamplifier (Axon Instruments) in single electrode volt-
age clamp mode with > 80 % series resistance compensa-
tion and > 5 GOhm seals. Patch-clamp current signals
were filtered (0.1 Hz to 10 KHz, bandpass), amplified (×
100) and digitized (10 KHz) for storage and analysis. Fre-
quency and amplitudes of IPSCs were analyzed using
Data Wave Technologies and Strathclyde Electrophysio-
logical software in a continuous data recording
configuration.
The intravenous anesthetics (propofol and pentobarbital)
were made fresh for each experiment, solubilized using
0.5% dimethyl sulfoxide (DMSO) and sonicated immedi-
ately prior to test administration in stock solutions and
serially diluted into ACSF to achieve the final concentra-
tions for testing. Volatile anesthetics (halothane and iso-
flurane) were applied in the perfusate at equilibrated
concentrations, delivered from calibrated vaporizers and
bubbled into the perfusate for at least 10 min prior to
switching from control ACSF, to ensure steady-state
concentrations were achieved. The concentration of vola-
tile anesthetics in the gas phase were continually meas-
ured using a Puritan-Bennett anesthetic monitor. Only a
single concentration of a given anesthetic was tested on
each brain slice.
Data are expressed as the mean ± standard deviation and
statistical analysis (ANOVA with post Tukey test) was per-
formed using Instat from GraphPad Software. For drug
effects on paired pulse inhibition, the percent change was
first calculated as: Drug 1st/Control 1st = (0.5 × 100) - 100
% = 50 % depression; and Drug 2nd/Control 2nd = (X ×
100) - 100 % = X % depression. Then the percent increaseBMC Neuroscience 2004, 5:52 http://www.biomedcentral.com/1471-2202/5/52
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in paired pulse inhibition was = (X / 50) × 100 %. This
approach has the advantage of normalizing paired
responses with respect to varying degrees of population
spike facilitation observed during control recordings, i.e.
differing degrees of EPSP facilitation on a background of
differing degrees of inhibition from preparation to
preparation.
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